[1]
C. Santomasi, “Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study”, Acta Biomed, vol. 94, no. 1, p. e2023028, Feb. 2023, doi: 10.23750/abm.v94i1.13474.